Ta. Wyatt et al., REGULATION OF HUMAN NEUTROPHIL DEGRANULATION BY LY-83583 AND L-ARGININE - ROLE OF CGMP-DEPENDENT PROTEIN-KINASE, The American journal of physiology, 265(1), 1993, pp. 30000201-30000211
The effects of guanosine 3',5'-cyclic monophosphate (cGMP) on the secr
etory response of activated human neutrophils were investigated using
LY-83583, an inhibitor of soluble guanylate cyclase, and L-arginine, t
he precursor of nitric oxide formation. A 30% release of myeloperoxida
se (MPO) and lactoferrin (LF) from the primary and specific granules,
respectively, was detected by enzyme-linked immunosorbent assay in adh
ered neutrophils stimulated with 0.1 muM N-formyl-methionyl-leucyl-phe
nylalanine (FMLP) or 20 muM A-23187. LY-83583 (100 muM) inhibited the
release of both LF and MPO after stimulation with FMLP or A-23187. Con
versely, preincubation of neutrophils with 0.5 mM L-arginine augmented
the release of LF and MPO in FMLP- and A-23187-stimulated cells. Conc
urrent with the increase in the degranulation response was an elevatio
n of cGMP levels in L-arginine-treated cells, while stimulated cGMP le
vels were reduced in LY-83583-treated cells. Furthermore, cGMP-depende
nt protein kinase (G-kinase) activity was reduced in LY-83583-treated
cells, as determined by the delay in G-kinase translocation to interme
diate filaments and the inhibition of vimentin phosphorylation. Degran
ulation, elevation of cGMP levels, and targeting of G-kinase were also
dependent on the concentration of A-23187 or FMLP. These data suggest
that activators of neutrophil degranulation mediate this response thr
ough a cGMP-dependent protein kinase mechanism.